Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Advin Biotech Inc. maintains a patent portfolio in the Chemistry & Materials technology area, currently involving 1 pending office action. This level of activity reflects the company's efforts to establish its intellectual property position within this technical sector. Successfully managing this 1 pending office action is essential for the company to secure the rights necessary for its chemical and material innovations. The Chemistry & Materials field requires precise technical disclosures to meet examination standards.
The prosecution of these assets is handled by 1 distinct examiner within 1 distinct art unit. This indicates that the review process is highly focused, with a single administrative unit responsible for evaluating the technical merits of the applications. Such a structure allows for a consistent application of examination standards across the portfolio. The use of 1 distinct art unit suggests that the subject matter is tightly defined within the Chemistry & Materials field for the 1 distinct examiner involved.
LYLE, SOPHIA YUAN is identified as the busiest examiner for Advin Biotech Inc., currently overseeing 1 busiest examiner pending office action. Because this official is the only examiner with a pending matter, their individual perspective and history are the primary factors in the current prosecution. Practitioners can focus their strategy on the specific requirements of LYLE, SOPHIA YUAN. This concentration of work under 1 distinct examiner simplifies the coordination of responses to the patent office.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LYLE, SOPHIA YUAN | 1 | 57.5% | +56.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17868525 | SAMPLE COLLECTOR | LYLE, SOPHIA YUAN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17868525 | SAMPLE COLLECTOR | LYLE, SOPHIA YUAN | — |
| Art Unit | Apps |
|---|---|
| 1796 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17868525 | SAMPLE COLLECTOR | LYLE, SOPHIA YUAN | 1796 | §102§103§112 | Non-Final OA | — | Pending | Jul 19, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAdvin Biotech Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Sophia Yuan Lyle has the most, with 1 of Advin Biotech Inc.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
